• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KDM2B 是一种组蛋白 H3K79 去甲基化酶,通过 SIRT1 介导的染色质沉默诱导转录抑制。

KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.

机构信息

Department of Life Science, College of Natural Sciences, Chung-Ang University, Seoul, South Korea.

Department of Pharmacology, Medical Research Center for Gene Regulation, Chonnam National University, Gwangju, South Korea.

出版信息

FASEB J. 2018 Oct;32(10):5737-5750. doi: 10.1096/fj.201800242R. Epub 2018 May 15.

DOI:10.1096/fj.201800242R
PMID:29763382
Abstract

The methylation of histone H3 lysine 79 (H3K79) is an active chromatin marker and is prominent in actively transcribed regions of the genome; however, demethylase of H3K79 remains unknown despite intensive research. Here, we show that KDM2B, also known as FBXL10 and a member of the Jumonji C family of proteins known for its histone H3K36 demethylase activity, is a di- and trimethyl H3K79 demethylase. We demonstrate that KDM2B induces transcriptional repression of HOXA7 and MEIS1 via occupancy of promoters and demethylation of H3K79. Furthermore, genome-wide analysis suggests that H3K79 methylation levels increase when KDM2B is depleted, which indicates that KDM2B functions as an H3K79 demethylase in vivo. Finally, stable KDM2B-knockdown cell lines exhibit displacement of NAD-dependent deacetylase sirtuin-1 (SIRT1) from chromatin, with concomitant increases in H3K79 methylation and H4K16 acetylation. Our findings identify KDM2B as an H3K79 demethylase and link its function to transcriptional repression via SIRT1-mediated chromatin silencing.-Kang, J.-Y., Kim, J.-Y., Kim, K.-B., Park, J. W., Cho, H., Hahm, J. Y., Chae, Y.-C., Kim, D., Kook, H., Rhee, S., Ha, N.-C., Seo, S.-B. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.

摘要

组蛋白 H3 赖氨酸 79(H3K79)的甲基化是一种活跃的染色质标记,在基因组中活跃转录的区域中很明显;然而,尽管进行了深入的研究,H3K79 的去甲基酶仍然未知。在这里,我们表明 KDM2B,也称为 FBXL10,是 Jumonji C 家族蛋白的成员,因其组蛋白 H3K36 去甲基酶活性而闻名,是二甲基和三甲基 H3K79 去甲基酶。我们证明 KDM2B 通过占据启动子和 H3K79 的去甲基化来诱导 HOXA7 和 MEIS1 的转录抑制。此外,全基因组分析表明,当 KDM2B 耗尽时,H3K79 甲基化水平增加,这表明 KDM2B 在体内作为 H3K79 去甲基酶发挥作用。最后,稳定的 KDM2B 敲低细胞系表现出 NAD 依赖性去乙酰化酶 SIRT1 从染色质上的位移,同时 H3K79 甲基化和 H4K16 乙酰化增加。我们的研究结果确定 KDM2B 为 H3K79 去甲基酶,并通过 SIRT1 介导的染色质沉默将其功能与转录抑制联系起来。-Kang,J.-Y.,Kim,J.-Y.,Kim,K.-B.,Park,J. W.,Cho,H.,Hahm,J. Y.,Chae,Y.-C.,Kim,D.,Kook,H.,Rhee,S.,Ha,N.-C.,Seo,S.-B. KDM2B 是一种组蛋白 H3K79 去甲基酶,通过 SIRT1 介导的染色质沉默诱导转录抑制。

相似文献

1
KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.KDM2B 是一种组蛋白 H3K79 去甲基化酶,通过 SIRT1 介导的染色质沉默诱导转录抑制。
FASEB J. 2018 Oct;32(10):5737-5750. doi: 10.1096/fj.201800242R. Epub 2018 May 15.
2
Histone H3K79 demethylation by KDM2B facilitates proper DNA replication through PCNA dissociation from chromatin.KDM2B 通过组蛋白 H3K79 的去甲基化作用促进 PCNA 从染色质上的解离,从而有助于正确的 DNA 复制。
Cell Prolif. 2020 Nov;53(11):e12920. doi: 10.1111/cpr.12920. Epub 2020 Oct 7.
3
Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.表观遗传酶赖氨酸(K)特异性去甲基酶 2B 与 Epstein-Barr 病毒感染之间的相互作用。
J Virol. 2019 Jun 14;93(13). doi: 10.1128/JVI.00273-19. Print 2019 Jul 1.
4
SRF is a nonhistone methylation target of KDM2B and SET7 in the regulation of skeletal muscle differentiation.SRF 是 KDM2B 和 SET7 在调节骨骼肌分化过程中非组蛋白甲基化的靶点。
Exp Mol Med. 2021 Feb;53(2):250-263. doi: 10.1038/s12276-021-00564-4. Epub 2021 Feb 9.
5
Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.组蛋白去甲基化酶 KDM2B 通过抑制 p15INK4B、p16INK4A 和 p57KIP2 的转录来促进三阴性乳腺癌的增殖。
Acta Biochim Biophys Sin (Shanghai). 2018 Sep 1;50(9):897-904. doi: 10.1093/abbs/gmy084.
6
Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1.组蛋白去甲基化酶 KDM2A 的耗竭通过去抑制 p15INK4B 和 p27Kip1 来抑制根尖乳头干细胞的增殖。
Mol Cell Biochem. 2013 Jul;379(1-2):115-22. doi: 10.1007/s11010-013-1633-7. Epub 2013 Apr 5.
7
Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of and the Locus via Interaction with the Histone Lysine Demethylase KDM2B.EBV 核抗原 3C 通过与组蛋白赖氨酸去甲基化酶 KDM2B 相互作用抑制 和 基因座的表达。
J Virol. 2018 Oct 12;92(21). doi: 10.1128/JVI.01362-18. Print 2018 Nov 1.
8
KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.KDM2B 参与 TGF-β 诱导的肺和胰腺癌细胞系上皮-间充质转化的表观遗传调控。
J Biol Chem. 2021 Jan-Jun;296:100213. doi: 10.1074/jbc.RA120.015502. Epub 2020 Dec 24.
9
Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4.KDM2B 对氨基酸代谢的转录调控,在 ncPRC1.1 的背景下,并与 MYC 和 ATF4 协同作用。
Metabolism. 2024 Jan;150:155719. doi: 10.1016/j.metabol.2023.155719. Epub 2023 Nov 6.
10
KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.KDM2B 通过 Polycomb 依赖性和非依赖性转录程序促进胰腺癌。
J Clin Invest. 2013 Feb;123(2):727-39. doi: 10.1172/JCI64535. Epub 2013 Jan 16.

引用本文的文献

1
SIRT1 as a potential target for age-related eye diseases: mechanisms and therapeutic strategies.SIRT1作为年龄相关性眼病的潜在靶点:作用机制与治疗策略
Hum Cell. 2025 Sep 7;38(6):155. doi: 10.1007/s13577-025-01285-w.
2
Molecular Mechanisms of KSHV Latency Establishment and Maintenance.卡波西肉瘤相关疱疹病毒潜伏感染的建立与维持的分子机制
Curr Clin Microbiol Rep. 2024 Dec;11(4):220-230. doi: 10.1007/s40588-024-00232-x. Epub 2024 Jul 19.
3
KDM2B variants in the CxxC domain impair its DNA-binding ability and cause a distinct neurodevelopmental syndrome.
CXXC结构域中的KDM2B变体损害其DNA结合能力,并导致一种独特的神经发育综合征。
Hum Mol Genet. 2025 Aug 16;34(16):1353-1367. doi: 10.1093/hmg/ddaf082.
4
TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signaling.TET2缺陷通过上调血小板生成素受体信号增强造血干细胞和祖细胞的竞争优势。
Nat Commun. 2025 Mar 10;16(1):2384. doi: 10.1038/s41467-025-57614-y.
5
Current advances and future directions in targeting histone demethylases for cancer therapy.靶向组蛋白去甲基化酶用于癌症治疗的当前进展与未来方向。
Mol Cells. 2025 Mar;48(3):100192. doi: 10.1016/j.mocell.2025.100192. Epub 2025 Feb 10.
6
Polycomb-associated and Trithorax-associated developmental conditions-phenotypic convergence and heterogeneity.多梳蛋白相关和三胸蛋白相关的发育病症——表型趋同与异质性
Eur J Hum Genet. 2025 Jan 22. doi: 10.1038/s41431-025-01784-2.
7
Histone demethylases in autophagy and inflammation.自噬与炎症中的组蛋白去甲基化酶
Cell Commun Signal. 2025 Jan 13;23(1):24. doi: 10.1186/s12964-024-02006-w.
8
KDM2B regulates stroke injury by modulating OGT-mediated 0-GlcNAcylation of SLC7A11.KDM2B 通过调节 OGT 介导的 SLC7A11 的 0-GlcNAc 化来调节中风损伤。
Commun Biol. 2024 Nov 18;7(1):1530. doi: 10.1038/s42003-024-07251-w.
9
CircMAPK1 induces cell pyroptosis in sepsis-induced lung injury by mediating KDM2B mRNA decay to epigenetically regulate WNK1.环状 MAPK1 通过介导 KDM2B mRNA 的衰减来调控 WNK1 从而诱导脓毒症诱导的肺损伤中的细胞焦亡。
Mol Med. 2024 Sep 19;30(1):155. doi: 10.1186/s10020-024-00932-6.
10
Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives.赖氨酸甲基化修饰在肿瘤免疫调节和免疫治疗中的作用:调控机制与展望
Biomark Res. 2024 Jul 30;12(1):74. doi: 10.1186/s40364-024-00621-w.